Trial Outcomes & Findings for Evaluation of the Performance of Two Contact Lenses Compared to a Marketed Lens (NCT NCT01484028)
NCT ID: NCT01484028
Last Updated: 2018-06-19
Results Overview
Monocular distance Snellen visual acuity (VA) scores were coverted to the algorithm of the minimal angle of resolution (LogMAR) scale based on the following formula: LogMAR = Log10 (VA/20) - a\*VAR, where Log10 = base 10 logarithm, VA = the Snellen denominator score, a = LogMAR stepsize coefficient and VAR = letter gained or missing in addition to the Snellen denominator score.
COMPLETED
NA
275 participants
Dispensing
2018-06-19
Participant Flow
Of those 275 enrolled subjects, 267 subjects were randomized and received the study article in the study. Two subjects were discontinued between the first and second periods.
Participant milestones
| Measure |
1DM/EADE
etafilcon A control lens worn daily during the first period of 7-9 days then etafilcon A for dark eyes worn daily during the second period of 7-9 days, with a 1-3 days of wash-out time between the 2 periods.
|
1DM/EALE
etafilcon A control lens worn daily during the first period of 7-9 days then etafilcon A for light eyes worn daily during the second period of 7-9 days, with a 1-3 days of wash-out time between the 2 periods.
|
EADE/1DM
etafilcon A for dark eyes worn daily during the first period of 7-9 days then etafilcon A control lens worn daily during the second period of 7-9 days, with a 1-3 days of wash-out time between the 2 periods.
|
EALE/1DM
etafilcon A for light eyes worn daily during the first period of 7-9 days then etafilcon A control lens worn daily during the second period of 7-9 days, with a 1-3 days of wash-out time between the 2 periods.
|
|---|---|---|---|---|
|
Period 1
STARTED
|
66
|
70
|
64
|
67
|
|
Period 1
COMPLETED
|
66
|
67
|
64
|
66
|
|
Period 1
NOT COMPLETED
|
0
|
3
|
0
|
1
|
|
Period 2
STARTED
|
66
|
67
|
64
|
66
|
|
Period 2
COMPLETED
|
66
|
67
|
64
|
66
|
|
Period 2
NOT COMPLETED
|
0
|
0
|
0
|
0
|
Reasons for withdrawal
| Measure |
1DM/EADE
etafilcon A control lens worn daily during the first period of 7-9 days then etafilcon A for dark eyes worn daily during the second period of 7-9 days, with a 1-3 days of wash-out time between the 2 periods.
|
1DM/EALE
etafilcon A control lens worn daily during the first period of 7-9 days then etafilcon A for light eyes worn daily during the second period of 7-9 days, with a 1-3 days of wash-out time between the 2 periods.
|
EADE/1DM
etafilcon A for dark eyes worn daily during the first period of 7-9 days then etafilcon A control lens worn daily during the second period of 7-9 days, with a 1-3 days of wash-out time between the 2 periods.
|
EALE/1DM
etafilcon A for light eyes worn daily during the first period of 7-9 days then etafilcon A control lens worn daily during the second period of 7-9 days, with a 1-3 days of wash-out time between the 2 periods.
|
|---|---|---|---|---|
|
Period 1
Lost to Follow-up
|
0
|
1
|
0
|
0
|
|
Period 1
Non-Compliance to Protocol
|
0
|
1
|
0
|
1
|
|
Period 1
Lens Discomfort
|
0
|
1
|
0
|
0
|
Baseline Characteristics
Evaluation of the Performance of Two Contact Lenses Compared to a Marketed Lens
Baseline characteristics by cohort
| Measure |
All Subjects
n=267 Participants
All randomized subjects who worn at least one pair of study lenses.
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
267 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
|
Age, Continuous
|
24.94 years
STANDARD_DEVIATION 4.654 • n=5 Participants
|
|
Sex: Female, Male
Female
|
267 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: DispensingPopulation: Analysis was conducted on all randomized subjects who wore at least one pair of study lenses.
Monocular distance Snellen visual acuity (VA) scores were coverted to the algorithm of the minimal angle of resolution (LogMAR) scale based on the following formula: LogMAR = Log10 (VA/20) - a\*VAR, where Log10 = base 10 logarithm, VA = the Snellen denominator score, a = LogMAR stepsize coefficient and VAR = letter gained or missing in addition to the Snellen denominator score.
Outcome measures
| Measure |
EADE/EALE
n=528 eyes
etafilcon A with embedded print and PVP for dark/light eyes to correct myopia.
|
1-DM
n=530 eyes
A marketed daily disposable contact lens to correct myopia.
|
|---|---|---|
|
Monocular Visual Acuity
|
-0.044 LogMAR score
Standard Deviation 0.0618
|
-0.060 LogMAR score
Standard Deviation 0.0589
|
PRIMARY outcome
Timeframe: DispensingPopulation: Analysis was conducted on all randomized subjects who wore at least one pair of study lenses.
The overall lens fit was evaluated by the Investigators for each eye whether it was acceptable (yes/no).
Outcome measures
| Measure |
EADE/EALE
n=528 eyes
etafilcon A with embedded print and PVP for dark/light eyes to correct myopia.
|
1-DM
n=530 eyes
A marketed daily disposable contact lens to correct myopia.
|
|---|---|---|
|
Lens Fit Acceptance
|
100 % of Eyes
Interval 98.3 to 100.0
|
100 % of Eyes
Interval 98.3 to 100.0
|
PRIMARY outcome
Timeframe: After 7-9 days of lens wearPopulation: Analysis was conducted on all randomized subjects who wore at least one pair of study lenses.
Corneal staining was graded using a 5-point scale; 0=None(no staining), 1=Trace, 2=Mild, 3=Moderate, and 4=Severe. Only those eyes with corneal staining grade \>= 3 were reported.
Outcome measures
| Measure |
EADE/EALE
n=528 eyes
etafilcon A with embedded print and PVP for dark/light eyes to correct myopia.
|
1-DM
n=526 eyes
A marketed daily disposable contact lens to correct myopia.
|
|---|---|---|
|
Corneal Staining of Grade 3 or 4
|
0 % of Eyes
Interval 0.0 to 1.7
|
0 % of Eyes
Interval 0.0 to 1.7
|
Adverse Events
Etafilcon A With PVP for Dark/Light Eyes
Etafilcon A Control Lenses
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Dr. Michael Mayers, O.D., FAAO, Senior Research Optometrist
Vistakon, Johnson and Johnson Vision Care
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place